// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Impact Of The Provision Of Transplant Information On Access To First And Repeat Kidney Transplantation

S. Clark - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

N/A

Impact of Vancomycin-Resistant Enterococci Gut Colonization on Liver Transplant Outcomes

D. Chiang - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acute renal failure

vancomycin capsule

In Vivo/In Situ Behaviour of Allogeneic Spleen versus Bone Marrow Cells in Wild-Type Neonatal Mice: Insights into Robust Transplant Tolerance Induction

R. A. Bascom - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Graft-versus-host disease

N/A

Inadequate (ax) Transbronchial Biopsies Are Not Associated With Clad Or Death After Lung Transplantation

L. Levy - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Incidence, Risk Factors, Outcomes and Clinical Management of BK Viremia in the Modern Era of Kidney Transplantation

J. Kim - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Indocyanine Green Fluorescence Imaging during Normothermic Ex Vivo Liver Perfusion for the Assessment of Hepatocyte, Biliary, and Vascular Function

T. Goto - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

International Multicenter Study Evaluating Clinical Outcomes Associated with Acute Antibody-Mediated Rejection

S. Corman - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic antibody mediated rejection

N/A

Kidney Evaluation in Living Kidney Donors: Survey of US Transplant Centers 2018

N. Garg - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Kidney Transplant Education outside the Transplant Center – Initial Experience with an On-Line Transplant Education Hub

D. Belenko - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Lack of Response to Tocilizumab in Kidney Transplants with Chronic Antibody-Mediated Rejection

D. Kumar - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Chronic antibody mediated rejection

Tocilizumab

Liver Transplant Candidate Attitudes towards Organs from Increased Risk Donors: A Single Center Survey

S. S. Humar - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Long-term Impact of Antihypertensive Treatment and Tacrolimus Dose in Renal Allograft Recipients 5 Years Post-Transplantation

D. Rush - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Acute cellular rejection

Mycophenolate mofetil

Mass Cytometry-Based Characterization of Adaptive Immunity in Transplant Recipients with Self-Limiting or Chronic EBV Viremia

V. H. Ferreira - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Post-transplant lymphoproliferative disorder

N/A

MELD Score and Anti-Angiotensin Receptor Antibody Predict Long-Term Survival of Liver Re-Transplant

Q. Xu - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Angiotensin II

Metabolic and Cardiovascular Evaluation in Living Kidney Donors: Survey of US Transplant Centers 2018

N. Garg - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Microvascular Rarefaction and Long-Term Graft Dysfunction in Kidney Transplant Recipients with Delayed Graft Function

A. Doreille - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Microvascular rarefaction

N/A

Mitochondrial Permeability Regulates Heart Graft Ischemia – Reperfusion Injury and Rejection

A. Qamar - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Modeling Patients as Dynamical Systems: Evaluating the Efficiency of Kidney Transplantation through Multi-Stage Data Envelopment Analysis

F. J. Santos Arteaga - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal insufficiency

N/A

Molecular Analysis of Rejection and Injury in Human Liver Transplant Biopsies: First Results of the INTERLIVER Study

P. F. Halloran - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Molecular Features of Rejection in Endobronchial Mucosa Biopsies

M. D. Parkes - American Transplant Congress (ATC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved